UK Watchdog Turns Down Liraglutide (Saxenda) for Obesity UK Watchdog Turns Down Liraglutide (Saxenda) for Obesity

UK NICE cites"highly uncertain" cost-effectiveness estimates for liraglutide (Saxenda) for obesity and questions the appropriateness of a subgroup analysis of the SCALE trial in a draft ruling.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news